RADICL

We build advanced autonomous systems and defense technology to protect US and allied forces. Our team comes from diverse backgrounds - some of us spent years at places like Palantir, while others joined directly from the military. We're united by a shared belief that the way we approach national security needs to fundamentally change. Instead of the traditional defense contractor model, we're taking a software-first approach to building hardware and AI systems that actually work in the real world. The challenges we tackle are complex, from autonomous undersea vehicles to counter-drone systems and solid rocket motors. We've grown quickly since 2017, but we've worked hard to maintain a culture where engineers can take ownership of projects that have real, material impact. We don't pretend this work is easy - building reliable defense systems that protect lives requires incredible attention to detail and relentless testing. But we believe it's some of the most meaningful work anyone can do right now.

At Rad AI, we believe the best healthcare AI is built by the very clinicians who use it every day. Founded in 2018 by Dr. Jeff Chang - the youngest radiologist in U.S. history - and serial entrepreneur Doktor Gurson, Rad AI grew from a simple observation: radiologists spend 75% of their time dictating reports instead of analyzing images. Our team of radiologists, engineers, and healthcare leaders work side-by-side to build solutions that feel less like software and more like an intelligent assistant designed by colleagues who understand the nuances of radiology workflow. We're not just shipping code - we're shipping relief. Our flagship products, Rad AI Impressions, Reporting, and Continuity, save radiologists over 60 minutes per shift by automatically generating impression sections customized to each physician's unique language style. The impact has been immediate: 84% of our users report reduced burnout, and we've helped health systems like Cone Health achieve 100% coverage for incidental findings while generating millions in additional revenue. With over $140M in funding from Khosla Ventures, Gradient Ventures, and World Innovation Lab, and recognition on Deloitte's Fast 500 and CNBC's Disruptor 50 list, we're scaling rapidly while staying true to our physician-led roots. Our engineers deploy to production daily, collaborate across functions with minimal bureaucracy, and maintain a remote-friendly culture optimized for focus, not facetime.

Vercel enables the world to ship the best products by providing the developer tools and cloud infrastructure to build, scale, and secure a faster, more personalized web. As the creators of Next.js and v0, Vercel is the Frontend Cloud that powers modern web development for companies like Under Armour, Ramp, Supreme, and PayPal. Every year, millions of websites struggle with slow load times, complex deployments, and security vulnerabilities. Vercel exists to change that - giving developers instant global deployments, automatic scaling, and edge performance out of the box. The platform combines workflow automation, git integration, and zero-configuration infrastructure so teams can push to production in seconds, not hours.

Velsera is a precision medicine technology company that accelerates the discovery, development, and delivery of life-changing insights through integrated AI-enhanced software and expert services. Formed in 2023 through the merger of Seven Bridges, PierianDx, and UgenTec, Velsera combines over two decades of experience working with leading diagnostic and pharma partners to solve cutting-edge problems in genomics and clinical diagnostics. The company partners with life science and clinical diagnostic organizations to provide multimodal data harmonization and analytics for drug discovery and development, IVD development and regulatory approval, and clinical NGS interpretation and reporting. Velsera's platform includes the Seven Bridges bioinformatics environment, Clinical Genomics Workspace, ARIA data harmonization platform, and an IVD-grade Knowledgebase for variant interpretation. With operations in the US, Europe, and Asia, Velsera serves top pharmaceutical companies, clinical diagnostic laboratories, NGS assay manufacturers, and non-profit organizations, processing over 250,000 NGS samples annually and supporting 80+ active clinical NGS lab customers.

CybelAngel operates an external threat intelligence platform that scans over 6 billion data points daily to identify exposures beyond traditional security perimeters - leaked credentials, shadow APIs, and impending data breaches before they cascade into incidents. Founded in 2013 by brothers Erwan and Stevan Keraudy, the company now employs more than 145 people across France, the United States, and the United Kingdom, serving enterprise clients in pharmaceuticals, manufacturing, retail, finance, and luxury brands. The platform's architecture combines machine learning detection with analyst-driven triage to reduce false positives and deliver contextual intelligence that integrates into SOC workflows. Rather than generating high-volume generic alerts, the team focuses on surfacing critical exposures with human expertise layered over automated scanning - targeting threat actors operating outside the org's direct visibility, including paste sites, dark web forums, and misconfigured cloud storage. Technical domains include credential leak detection, API security, and data breach prevention, with continuous monitoring positioned as a complement to perimeter defenses. CybelAngel's model emphasizes actionable intelligence: analysts provide prioritization and context to help security teams focus on immediate threats rather than sorting through noise. The platform's daily scanning volume and multi-geography presence indicate infrastructure built for scale, with machine learning models trained to surface anomalies that warrant human review. The company positions itself in the external attack surface management space, addressing risks that emerge from third-party integrations, supply chain exposure, and shadow IT.

RELX is a global provider of information-based analytics and decision tools for professional and business customers, enabling them to make better decisions, get better results and be more productive. We serve customers in more than 180 countries and have offices in about 40 countries, employing over 36,000 people worldwide. Our purpose is to benefit society by developing products that help researchers advance scientific knowledge, doctors and nurses improve patient lives, lawyers promote the rule of law, businesses and governments prevent fraud, and consumers access fair financial services and insurance. We operate across four major market segments: Risk, Scientific, Technical & Medical, Legal, and Exhibitions. Each day, our employees are inspired to undertake initiatives that make unique contributions to society and the communities in which we operate. By bringing clarity to information, we ultimately help make communities safer, insurance rates more accurate, commerce more transparent, processes more efficient and business decisions easier. Our purpose guides our actions beyond the products we develop - it defines us as a company committed to making a meaningful difference through information and analytics.